Home > France recommends reserving AstraZeneca vaccine for over 55s despite EMA advice

News
France recommends reserving AstraZeneca vaccine for over 55s despite EMA advice

Description

Despite resuming the rollout of the AstraZeneca vaccine, France's health authority has recommended reserving it for people aged 55 and over.

Added on the 19/03/2021 19:01:36 - Copyright : Euronews EN

To customise your video :

Or Create an account

More videos on the subject

  • AstraZeneca vaccine benefits increase with age: EMA

    The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits increase with age, despite links to blood clots. SOUNDBITE

    23/04/2021 - AFPTV - First images
  • EMA review finds AstraZeneca benefits still outweigh risks

    The deputy executive director of EU's drug watchdog says during a press conference that a review of AstraZeneca's Covid-19 vaccine found its benefits still outweigh the risks for adults despite links to blood clots. SOUNDBITE

    23/04/2021 - AFPTV - First images
  • French PM receives a dose of AstraZeneca vaccine

    French Prime Minister Jean Castex receives a dose of AstraZeneca's Covid-19 vaccine, as France resumes its vaccination programme with AstraZeneca's dose, following the European regulator's conclusions that the vaccine is "safe and effective". (COMPLETES VID96C8WU_EN) IMAGES

    19/03/2021 - AFPTV - First images
  • EU regulator says AstraZeneca vaccine 'safe and effective'

    Executive Director of the European Medicines Agency (EMA) Emer Cook says the AstraZeneca vaccine is "safe and effective" and not associated with a higher blood clot risk, after more than a dozen countries paused rollouts over health fears. IMAGES

    18/03/2021 - AFPTV - First images
  • EU regulator 'looking at adverse events associated with all vaccines'

    The head of the EU's medicines regulator says that it is probing serious side effects of "all vaccines", as it investigated possible blood clots linked to the AstraZeneca jab. SOUNDBITE

    16/03/2021 - AFPTV - First images
  • EU regulator 'firmly convinced' of AstraZeneca benefits

    The EU's drug regulator says it remains "firmly convinced" of the benefits of AstraZeneca's coronavirus vaccine despite several countries suspending its use over blood clot fears. SOUNDBITE

    16/03/2021 - AFPTV - First images

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32